Cardiovascular chemotherapy: anticoagulants

This publication has 41 references indexed in Scilit:

• A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement
  New England Journal of Medicine, 1997
• Genetic association between sensitivity to warfarin and expression of CYP2C9*3
  Pharmacogenetics, 1997
• Low-Molecular-Weight Heparin in the Treatment of Patients with Venous Thromboembolism
  New England Journal of Medicine, 1997
• Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective
  Archives of internal medicine (1960), 1997
• Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip Replacement
  New England Journal of Medicine, 1996
• Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo
  The Lancet, 1996
• Prevention of Venous Thromboembolism
  Chest, 1995
• Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery.
  Circulation, 1994
• A meta-analysis of methods to prevent venous thromboembolism following total hip replacement
  JAMA, 1994
• A Comparison of Subcutaneous Low-Molecular-Weight Heparin with Warfarin Sodium for Prophylaxis against Deep-Vein Thrombosis after Hip or Knee Implantation
  New England Journal of Medicine, 1993